In-Depth Analysis of Carfilzomib in Myeloma Treatment

This chapter explores carfilzomib, a crucial proteasome inhibitor for treating multiple myeloma, detailing its mechanism of action and comparing it with bortezomib. It also covers dosing regimens, potential toxicities, and recent studies to enhance clinical practice and patient outcomes.